Skip to content

Research at St Andrews

Lancet Neurology, 1474-4422


  1. 2014
  2. Published

    Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): A multicentre, randomised, double-blind extension trial

    Giovannoni, G., Gold, R., Selmaj, K., Havrdova, E., Montalban, X., Radue, E. W., Stefoski, D., McNeill, M., Amaravadi, L., Sweetser, M., Elkins, J. & O'Neill, G., 2014, In : Lancet Neurology. 13, 5, p. 472-481 10 p.

    Research output: Contribution to journalArticle

ID: 14374056